PATH | VRL
Menu

A Forecast of Typhoid Conjugate Vaccine Introduction and Demand in Typhoid Endemic Low- and Middle-Income Countries to Support Vaccine Introduction Policy and Decisions

This article, published in Human Vaccines & Immunotherapeutics, describes the results of a demand forecast for the typhoid conjugate vaccine (TCV) that includes introduction dates for countries based on specific criteria and estimated vaccine demand by year for defined vaccination strategies in two scenarios: rapid vaccine introduction and slow vaccine introduction. The rapid introduction scenario estimated annual demand ranging from 40 million to 160 million doses, depending on the vaccination strategy. The authors conclude that the demand forecast can inform country-level vaccine introduction policies and decisions for TCV, though actual demand will depend on a number of factors, including country priorities and strategies, Gavi financing, and the overall product profile.

Author: Mogasale V, Ramani E, Park IY, Lee JS

Published: 2017

» Visit web page (English)

(Located at www.tandfonline.com)

Citation: Mogasale V, Ramani E, Park IY, Lee JS. A Forecast of Typhoid Conjugate Vaccine Introduction and Demand in Typhoid Endemic Low- and Middle-Income Countries to Support Vaccine Introduction Policy and Decisions. Human Vaccines & Immunotherapeutics. 2017;Early Online Publication.  

Resource types: Peer-reviewed journal

Diseases/vaccines: Typhoid

Topics: Introduction and service delivery, Disease/vaccine specific information

Regions: Global